Clinical trial NCT00471705 - References

Cutaneous Leishmaniasis — Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

Citation(s)

•   1
  World Health Organization. Division of Control of Tropical Diseases. Leishmaniasis control home page. [Consultado: 20 de septiembre de 2006]. Disponible en: www.who.int/health-topics/leishmaniasis.htm
•   2
  Echeverry Gaitan MC, Gaona Narváez J, Gualtero SM. Guia de Atención de Leishmaniasis. Revisión y actualización. 2006.
•   Agudelo LA, Uribe J, Sierra D, Ruiz F, Velez ID
  Presence of American cutaneous Leishmaniasis vectors surrounding the city of Medellín, Colombia. Mem Inst Oswaldo Cruz. 2002 Jul;97(5):641-2.
•   Alvaro Ruíz Morales, Luis Enrique Morrillo Zárate
  Epidemiología clínica. Bogotá, Editorial Médica Panamericana
•   Amato V, Amato J, Nicodemo A, Uip D, Amato-Neto V, Duarte M
  [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate]. Ann Dermatol Venereol. 1998 Aug;125(8):492-5. French.
•   Amato VS, de Paula JG, Imamura R, Amato Neto V, Duarte MI, Boulos MI, Boulos M, Nicodemo AC, de Mendonca JS
  [Treatment of american cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate]. Rev Soc Bras Med Trop. 1996 Sep-Oct;29(5):477-81. Portuguese.
•   Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD
  Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Am J Trop Med Hyg. 2005 Feb;72(2):133-7.
•   Angulo VM, Tarazona Z, Vega A, Vélez Bernal ID, Betancur Martinez J
  Leismaniosis Chagas y Malaria. 27-41. 2002. Colombia, Ascofame.
•   Bejarano EE, Uribe S, Rojas W, Dario Velez I
  Phlebotomine sand flies (Diptera: Psychodidae) associated with the appearance of urban Leishmaniasis in the city of Sincelejo, Colombia. Mem Inst Oswaldo Cruz. 2002 Jul;97(5):645-7.
•   Bejarano EE, Uribe S, Rojas W, Vélez ID
  Presence of Lutzomyia evansi, a vector of American visceral leishmaniasis, in an urban area of the Colombian Caribbean coast. Trans R Soc Trop Med Hyg. 2001 Jan-Feb;95(1):27-8.
•   Berman J
  Report to 1999 Miltefosine PDT of the phase II study. 1999. WHO/TDR.
•   Berman JD, Neva FA
  Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro. Am J Trop Med Hyg. 1981 Mar;30(2):318-21.
•   Berman JD
  Treatment of New World cutaneous and mucosal leishmaniases. Clin Dermatol. 1996 Sep-Oct;14(5):519-22.
•   Correia D, Macêdo VO, Carvalho EM, Barral A, Magalhães AV, de Abreu MV, Orge ML, Marsden P
  [Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis]. Rev Soc Bras Med Trop. 1996 Sep-Oct;29(5):447-53. Portuguese.
•   Croft SL, Coombs GH
  Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 2003 Nov;19(11):502-8. Review.
•   Croft SL, Neal RA, Pendergast W, Chan JH
  The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem Pharmacol. 1987 Aug 15;36(16):2633-6.
•   Croft SL, Snowdon D, Yardley V
  The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother. 1996 Dec;38(6):1041-7.
•   de Paula CD, Sampaio JH, Cardoso DR, Sampaio RN
  [A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis]. Rev Soc Bras Med Trop. 2003 May-Jun;36(3):365-71. Epub 2003 Jul 31. Portuguese.
•   Delobel P, Pradinaud R
  Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis. J Antimicrob Chemother. 2003 May;51(5):1319-20. Epub 2003 Mar 28.
•   Franke ED, Lucas CM, Tovar AA, Kruger JH, De Rivera MV, Wignall FS
  Diffuse cutaneous leishmaniasis acquired in Peru. Am J Trop Med Hyg. 1990 Sep;43(3):260-2.
•   Franke ED, Wignall FS, Cruz ME, Rosales E, Tovar AA, Lucas CM, Llanos-Cuentas A, Berman JD
  Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med. 1990 Dec 15;113(12):934-40.
•   Hauben M, Reich L
  A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigation. Br J Clin Pharmacol. 2004 Dec;58(6):675-6.
•   Hendrickx EP, Agudelo SP, Munoz DL, Puerta JA, Velez Bernal ID
  Lack of efficacy of mefloquine in the treatment of New World cutaneous leishmaniasis in Colombia. Am J Trop Med Hyg. 1998 Dec;59(6):889-92.
•   Hepburn NC, Nolan J, Fenn L, Herd RM, Neilson JM, Sutherland GR, Fox KA
  Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies. QJM. 1994 Aug;87(8):465-72.
•   Hepburn NC, Tidman MJ, Hunter JA
  Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):700-3.
•   Herwaldt BL, Arana BA, Navin TR
  The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis. 1992 Mar;165(3):518-27.
•   Herwaldt BL
  Leishmaniasis. Lancet. 1999 Oct 2;354(9185):1191-9. Review.
•   Invetigator's Brochure Miltefosine
  D-18506. 27-10-1999. Frankfurt, Alemania, ASTA Medica
•   Kreutzer RD, Corredor A, Grimaldi G Jr, Grogl M, Rowton ED, Young DG, Morales A, McMahon-Pratt D, Guzman H, Tesh RB
  Characterization of Leishmania colombiensis sp. n (Kinetoplastida: Trypanosomatidae), a new parasite infecting humans, animals, and phlebotomine sand flies in Colombia and Panama. Am J Trop Med Hyg. 1991 Jun;44(6):662-75.
•   Kuhlencord A, Maniera T, Eibl H, Unger C
  Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob Agents Chemother. 1992 Aug;36(8):1630-4.
•   Leandro C, Campino L
  Leishmaniasis: efflux pumps and chemoresistance. Int J Antimicrob Agents. 2003 Sep;22(3):352-7. Review.
•   Lieber-Mbomeyo A, Lipsker D, Miléa M, Heid E
  [Rhabdomyolysis induced by pentamidine (Pentacarinat) during treatment of cutaneous leishmaniasis: 2 cases]. Ann Dermatol Venereol. 2002 Jan;129(1 Pt 1):50-2. French.
•   Lightburn E, Morand JJ, Meynard JB, Kraemer P, Chaudier B, Pages F, Garnotel E, Patte JH, Banzet S, Dampierre H, Lepage J, Morillon M, Boutin JP, Hovette P, Chouc C
  [Management of American cutaneous leishmaniasis. Outcome apropos of 326 cases treated with high-dose pentamidine isethionate]. Med Trop (Mars). 2003;63(1):35-44. French.
•   Marsden PD
  Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg. 1986;80(6):859-76. Review.
•   Ministerio de Proteccion Social, Instituto Nacional de Salud, and SIVIGILA
  informe Leishmaniasis semestre 2005. http://www.ins.gov.co/pdf/vcsp/informe_leishmanisis_1sem_2005.pdf. Fecha de acceso: 09/22/06
•   Navin TR, Arana BA, Arana FE, Berman JD, Chajón JF
  Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis. 1992 Mar;165(3):528-34.
•   Navin TR, Arana BA, Arana FE, de Mérida AM, Castillo AL, Pozuelos JL
  Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg. 1990 Jan;42(1):43-50.
•   Neva FA, Petersen EA, Corsey R, Bogaert H, Martinez D
  Observations on local heat treatment for cutaneous leishmaniasis. Am J Trop Med Hyg. 1984 Sep;33(5):800-4.
•   Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM
  Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol. 2002 Oct;18(10):421-6. Review.
•   Robledo SM, Puerta JA, Muñoz DL, Guardo M, Vélez ID
  [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia]. Biomedica. 2006 Oct;26 Suppl 1:188-93. Spanish.
•   Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG
  Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis. 2006 May 15;193(10):1375-83. Epub 2006 Apr 7.
•   Sacks DL, Barral A, Neva FA
  Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg. 1983 Mar;32(2):300-4.
•   Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Goncalves A
  Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection? Lancet. 1990 Aug 18;336(8712):398-402.
•   Singh S, Sivakumar R
  Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother. 2004 Dec;10(6):307-15. Review.
•   Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H
  Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis. 2004 May 1;38(9):1266-72. Epub 2004 Apr 9.
•   Soto J, Buffet P, Grogl M, Berman J
  Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg. 1994 Jan;50(1):107-11.
•   Soto-Mancipe J, Grogl M, Berman JD
  Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis. 1993 Mar;16(3):417-25.
•   Sundar S, Rosenkaimer F, Makharia MK, Goyal AK, Mandal AK, Voss A, Hilgard P, Murray HW
  Trial of oral miltefosine for visceral leishmaniasis. Lancet. 1998 Dec 5;352(9143):1821-3.
•   Thakur CP, Kumar M, Pandey AK
  Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am J Trop Med Hyg. 1991 Oct;45(4):435-41.
•   Velasco-Castrejon O, Walton BC, Rivas-Sanchez B, Garcia MF, Lazaro GJ, Hobart O, Roldan S, Floriani-Verdugo J, Munguia-Saldana A, Berzaluce R
  Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg. 1997 Sep;57(3):309-12.
•   Vélez Bernal ID, Rodriguez Garcia E, Duarte Forero R, López Carvajal L, Castaño Arbeláez M
  Enfermedades Tropicales. Guia de manejo de ETV y accidente ofídico. 17-55. 2005. Colombia, PECET
•   Velez ID, Hendrickx E, Robledo SM, del Pilar Agudelo S
  [Gender and cutaneous leishmaniasis in Colombia]. Cad Saude Publica. 2001 Jan-Feb;17(1):171-80. Spanish.
•   Verweij J, Planting A, van der Burg M, Stoter G
  A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours. J Cancer Res Clin Oncol. 1992;118(8):606-8.
•   Wilcocks & Manson-Bahr
  Manon's tropical diseases.London: Bailliére Tindall; 1972. p. 119-33.

Phase 3 Open-label Study of Efficacy and Safety of Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis in Colombia.

Details for clinical trial NCT00471705